Suppr超能文献

低 keV 门静脉期作为胰腺期的替代在胰腺协议双能 CT 中的可行性、图像质量和病变显示度。

Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.

机构信息

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, White 270, 55 Fruit Street, White 270, Boston, MA, 02114, USA.

Department of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.

出版信息

Eur Radiol. 2021 Sep;31(9):6898-6908. doi: 10.1007/s00330-021-07744-w. Epub 2021 Mar 20.

Abstract

OBJECTIVE

To assess the feasibility of a proposed pancreatic protocol CT generated from portal-venous phase (PVP) dual-energy CT (DECT) acquisition and its impact on image quality, lesion conspicuity, and arterial visualization/involvement.

METHODS

We included 111 patients (mean age, 66.8 years) who underwent pancreatic protocol DECT (pancreatic phase, PP, and PVP). The original DECT acquisition was used to create two data sets-standard protocol (50 keV PP/65 keV PVP) and proposed protocol (40 keV/65 keV PVP). Three reviewers evaluated the two data sets for image quality, lesion conspicuity, and arterial visualization/involvement using a 5-point scale. The signal-to-noise ratio (SNR) of pancreas and lesion-to-pancreas contrast-to-noise ratio (CNR) was calculated. Qualitative scores, quantitative parameters, and dose-length product (DLP) were compared between standard and proposed protocols.

RESULTS

The image quality, SNR of pancreas, and lesion-to-pancreas CNR of the standard and proposed protocol were comparable (p = 0.11-1.00). Lesion conspicuity was comparable between the standard and proposed protocols for pancreatic ductal adenocarcinoma (p = 0.55) and pancreatic cysts (p = 0.28). The visualization of larger arteries and arterial involvement were comparable between the two protocols (p = 0.056-1.00) while the scores were higher for smaller vessels in the standard protocol (p < 0.0001-0.0015). DLP of the proposed protocol (670.4 mGy·cm) showed a projected 42% reduction than the standard protocol (1145.9 mGy·cm) (p < 0.0001).

CONCLUSION

Pancreatic protocol CT generated from a single PVP DECT acquisition is feasible and could potentially be an alternative to the standard pancreatic protocol with PP and PVP.

KEY POINTS

• The lesion conspicuity for focal pancreatic lesions was comparable between the proposed protocol and standard dual-phase pancreatic protocol CT. • Qualitative and quantitative image assessments were almost comparable between two protocols. • The radiation dose of a proposed protocol showed a projected 42% reduction from the conventional protocol.

摘要

目的

评估从门静脉期(PVP)双能 CT(DECT)采集生成拟议胰腺方案 CT 的可行性及其对图像质量、病灶显影和动脉可视化/受累的影响。

方法

我们纳入了 111 例患者(平均年龄 66.8 岁),他们接受了胰腺方案 DECT(胰腺期,PP 和 PVP)检查。使用原始 DECT 采集创建了两个数据集-标准方案(50keV PP/65keV PVP)和拟议方案(40keV/65keV PVP)。三位审阅者使用 5 分制评估了两个数据集的图像质量、病灶显影和动脉可视化/受累情况。计算胰腺的信噪比(SNR)和病灶-胰腺对比噪声比(CNR)。比较了标准和拟议方案之间的定性评分、定量参数和剂量长度乘积(DLP)。

结果

标准和拟议方案的图像质量、胰腺 SNR 和病灶-胰腺 CNR 相当(p=0.11-1.00)。标准和拟议方案中胰腺导管腺癌(p=0.55)和胰腺囊肿(p=0.28)的病灶显影相当。较大动脉的可视化和动脉受累情况在两个方案之间相当(p=0.056-1.00),而标准方案中小血管的评分更高(p<0.0001-0.0015)。拟议方案的 DLP(670.4mGy·cm)比标准方案(1145.9mGy·cm)预计减少 42%(p<0.0001)。

结论

从门静脉期 DECT 采集生成的胰腺方案 CT 是可行的,可能是具有胰腺期和门静脉期的标准胰腺方案 CT 的替代方案。

关键点

  1. 拟议方案与标准双期胰腺方案 CT 相比,局灶性胰腺病变的病灶显影相当。

  2. 两个方案的定性和定量评估几乎相当。

  3. 拟议方案的辐射剂量预计比常规方案减少 42%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验